Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 27, 2009 08:45 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Announces a Presentation At the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting

REDWOOD CITY, Calif., May 27, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced a presentation of clinical trial results on its hypoxia-activated prodrug, TH-302....
May 07, 2009 08:35 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Reports First Quarter 2009 Financial Results

REDWOOD CITY, Calif., May 7, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today reported financial results for the first quarter ended March 31, 2009. The net loss for the...
April 20, 2009 08:25 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Presents Positive TH-302 Preclinical Results in Three Scientific Presentations At AACR Annual Meeting

REDWOOD CITY, Calif., April 20, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced multiple preclinical presentations on its clinical stage hypoxia-activated...
April 14, 2009 09:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Announces Multiple Presentations At the 2009 American Association for Cancer Research (AACR) Annual Meeting

REDWOOD CITY, Calif., April 14, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced multiple presentations on its hypoxia-activated prodrug, TH-302. The...
March 19, 2009 08:30 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Announces Going Concern Opinion

REDWOOD CITY, Calif., March 19, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that its audited financial statements for the fiscal year ended December 31,...
March 11, 2009 08:30 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Announces Upcoming Presentation On TH-302 At the New York Academy of Sciences Hypoxia Meeting

REDWOOD CITY, Calif., March 11, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Charles P. Hart, Ph.D., Vice President of Biology, will present at the New...
March 05, 2009 08:30 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results

REDWOOD CITY, Calif., March 5, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today reported financial results for the fourth quarter and the year ended December 31,...
February 05, 2009 08:55 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold to Present At BIO CEO & Investor Conference On February 9

REDWOOD CITY, Calif., Feb. 5, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Barry Selick, Ph.D., Chief Executive Officer, will present at the BIO CEO...
November 19, 2008 16:05 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Appoints Dr. Jeffrey W. Bird to Board of Directors

REDWOOD CITY, Calif., Nov. 19, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that the Company has appointed Dr. Jeffrey W. Bird to its board of directors. Dr....
November 13, 2008 08:25 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold to Present At the Lazard Capital Markets Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 13, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced that it will present at the Lazard Capital Markets 5th Annual Healthcare...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right